By Siddhi Mahatole July 7 (Reuters) - The U.S. Food and Drug Administration has approved Vera Therapeutics' drug to treat ...
Shares of Vera Therapeutics rose about 8% Tuesday after the Food and Drug Administration approved its treatment for a kidney ...
Vera Therapeutics' Trutakna received an early, fast-tracked approval from the FDA to reduce proteinuria in adults with ...
Finerenone shows promise in slowing chronic kidney disease progression in non-diabetic patients, according to recent global ...
Preview this article 1 min Trutakna — a once-a-week, self-injected drug — could carry a wholesale price of nearly $400,000 a ...
MedPage Today on MSN
Chronic kidney disease increasingly driven by diabetes
Despite treatment advances, kidney disease burden remained unchanged over the past decade ...
Michelle Williams struggled with high blood pressure and swelling for years before she was finally diagnosed with an unusual ...
Paul Makulinski, a firefighter and EMT, celebrates a "second chance at life" after a life-saving kidney transplant on his ...
A new study found that people with systemic lupus erythematosus (SLE) may face a significantly higher risk of developing ...
Women diagnosed early in pregnancy with a fetus lacking adequate kidney function to make the urine that serves as vital ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results